Hint mode is switched on Switch off
For swift navigation between sections

Meda AB

Organization name
Meda AB
Country name
Sweden
Country of registration
Sweden
Industry
Miscellaneous Healthcare: Products and Services
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds
  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Meda AB is a Sweden-based company active in the specialty pharmaceuticals sector. Its portfolio comprises products in the areas of respiratory, cardiology, pain and inflammation, dermatology, gastroenterology and CNS (central nervous system), as well as a range of over the counter (OTC) products. Its operations are organized in four functions. Sales and marketing is active in Europe and the Unites States, among others. Drug development includes clinical development, regulatory activities, and department for pharmaceutical development. Manufacturing is engaged in ensuring the flow of products to Meda AB’s marketing companies. Administration consists of the Company’s finance department, covering performance, compliance and risk management; and Group Services department comprising corporate legal functions, brand management and human resources (HR) administration. Its subsidiaries include Acton Pharmaceuticals Inc and Rottapharm.

Awards

Documentation

Stocks

Latest issues

Public debt by currencies

Codes

  • CIK
    0001411795
Registration is required to get access.